Cocaine is known to increase the extracellular levels of dopamine (DA) and serotonin HT) by inhibiting the neuronal reuptake of these monoamines. However, individuals with reduced 4 monoamine reuptake transporter expression do not display a reduction in cocaine intake, 5 suggesting that a mechanism other than inhibition of monoamine reuptake contributes to the 6 rewarding and addictive effects of the psychostimulant. Here we report that cocaine depletes the 7 dopaminergic and serotonergic storage vesicles of the rat nucleus accumbens. This cocaine-8 induced vesicle depletion gave rise to acute increases in the extracellular levels of DA and 5-HT, 9 which in turn correlated with monoamine-type-specific changes in behavior. Both the 10 neurochemical and behavioral responses to cocaine varied among individual animals, which was 11 not due to individual differences in the reuptake of DA and 5-HT, but rather to individual 12 differences in their vesicular release. Furthermore, we found that reserpine-induced depletion of 13 storage vesicles reduced both short and long access cocaine self-administration, and the degree of 14 reduction was linked to the vesicular storage capacity of the animals. In conclusion, we 15 demonstrate a novel mechanism by which cocaine increases the extracellular concentrations of 16 accumbal DA and 5-HT, namely via release from storage vesicles. Furthermore, individual 17 differences in cocaine-induced vesicular monoamine release shape individual differences in not 18 only the acute behavioral and neurochemical effects of the stimulant, but also in its intake. Thus, 19 intracellular storage vesicles represent an attractive novel drug target to combat psychostimulant 20 addiction. 21 22 Keywords 23 24 Cocaine pharmacology; cocaine mode of action; cocaine mechanism of action; vesicular 25 monoamine release; storage vesicle depletion; synaptic vesicle depletion. Results 109 110 COC results in vesicular monoamine release that is correlated with changes in walking and 111 rearing behavior 112 113
Introduction 27
28 Cocaine (COC) is a powerful psychostimulant that produces short-term euphoria and often 29 leads to addiction. Addiction to COC not only destroys lives of users, but also of their relatives. 30 Presently, there are no FDA-approved drugs to treat COC addiction. Dopamine (DA) is well 31 known to mediate COC effects [1] [2] [3] [4] , but recent evidence suggests that serotonin (5-HT) plays an 32 important role in the neurochemical and behavioral effects of COC as well [5] [6] [7] [8] [9] . For instance, 33 COC administration increases whereas COC withdrawal decreases the extracellular levels of both 34 DA and 5-HT in the nucleus accumbens [9] [10] [11] [12] [13] . Moreover, in addition to accumbal DA receptors, 35 accumbal 5-HT receptors have been found to mediate COC-induced locomotor activity and COC 36 reward [14] [15] [16] [17] [18] [19] [20] . 37 COC is known to increase extracellular monoamine levels by blocking plasmalemmal 38 monoamine reuptake transporters [21] . However, the behavioral response to and the intake of COC 39 is not reduced in animals and humans that are marked by a reduction of monoamine reuptake 40 transporters [7, 8, [22] [23] [24] [25] [26] . In addition, we and others have found that an acute COC challenge still 41 resulted in an increase in the extracellular levels of DA and 5-HT in the nucleus accumbens of 42 animals lacking plasmalemmal DA and 5-HT transporters [9, [27] [28] [29] . False neurotransmitter 43 uptake could explain these findings, but it has been shown that COC-induced increases in the 44 accumbal extracellular levels of a particular monoamine (eg DA) are not explained by COC-45 mediated inhibition of another monoamine (eg 5-HT) transporter [30] . These findings suggest that 46 a mechanism other than DA and 5-HT reuptake inhibition may contribute to the rewarding and 47 addictive effects of COC. Interestingly, in 1977 Scheel-Krüger and co-workers have shown that 48 the behavioral response to COC also depends on the presence of monoaminergic storage vesicles 49 [see 31] . These observations led us to the hypothesis that COC releases DA and 5-HT into the 50 synaptic cleft by depleting presynaptic storage vesicles. 51 4/35 In the present study, we have isolated the presynaptic monoaminergic storage vesicles of 52 the rat nucleus accumbens, and measured COC-induced changes in the intra-vesicular as well as 53 extracellular levels of accumbal DA and 5-HT. We show that COC depletes accumbal 54 dopaminergic and serotonergic storage vesicles. Furthermore, we demonstrate that this COC-55 induced release of vesicular DA and 5-HT correlates with an increase in walking and rearing, 56 respectively, and that individual-specific increases in the extracellular DA and 5-HT response to 57 COC are due to individual differences in vesicular monoaminergic storage capacity. Finally, we 58
show that depletion of monoaminergic storage vesicles inhibits the voluntary short and long access 59 intake of COC. 60
Materials and methods 61
Rats 63
64
All experiments were performed in adult male Wistar rats, bred at the Central Animal 65
Facility of the Radboud University, Nijmegen, the Netherlands. Given the individual differences 66
in COC-induced vesicle depletion observed during the first experiment, the remaining 3 67 experiments were performed in High Responder (HR) and Low Responder (LR) to novelty rats, 68
which have previously been found to differ in the expression of vesicular monoamine transporters 69 type 2 (VMAT-2) [32] . All experiments were performed in accordance with institutional, national Unselected rats received a single injection of COC (dose: 45 mg/kg) or saline (volume: 1 77 ml/kg, i.p.) and walking and rearing behavior was recorded. After 20 min, these rats were 78 sacrificed by decapitation, bilateral punches of nucleus accumbens sections were collected [33, 79 34] , and storage vesicles were isolated by ultracentrifugation according to the protocol of Staal et 80 al., 2000 [35] . Afterwards, the accumbal vesicles were disrupted by osmotic shock and sonication 81 and their content was injected into a High Performance Liquid Chromatography (HPLC) system 82 coupled to an electrochemical detector (ECD) for the separation and quantification of the vesicular 83 levels of DA and 5-HT. 84 6/35
Experiments 2-4 86

87
HR and LR to novelty rats were selected on a novel open field according to procedures 88 previously described by Cools et al., 1990 [36] and the accumbal levels of plasmalemmal DA and 89 5-HT uptake [for procedures, see 37, 38] , in addition to the accumbal total and vesicular levels of 90 DA and 5-HT (for procedures, see above), were measured. A second group of HR and LR rats 91 underwent stereotactic surgery to implant a microdialysis probe into the right nucleus accumbens 92 [see 39]. After recovery, these rats were injected with the vesicle depleting agent reserpine (RES, 93 doses: 1 or 2 mg/kg) or its solvent (volume: 1 ml/kg, i.p.), and 24 h later accumbal levels of 94 extracellular DA and 5-HT were measured using the above-mentioned HPLC-ECD setup. When 95 the RES-induced reduction of the extracellular levels of accumbal DA and 5-HT was stable, the 96 HR and LR rats of the second group were also injected with COC (dose: 15 mg/kg) or saline 97 (volume: 1 ml/kg, i.p.), where after the extracellular accumbal levels of these monoamines as well 98 as walking and rearing were measured for an additional period of 120 min. A third, and final, 99 group of HR and LR rats was implanted with a catheter into the right external jugular vein [40] 100 and, after training, COC self-administration (0.5 mg/kg/infusion) was performed for daily 1-h 101 (short access) or 6-h (long access) sessions [for details 41, 42] . When the COC intake reached a 102 stable level, rats were also treated with RES (dose: 1 or 2 mg/kg) or its solvent (volume: 1 ml/kg, 103 i.p.), where after they were exposed to their corresponding COC self-administration sessions for 104 an additional period of 6 days. Ultracentrifugation was used to isolate the storage vesicles of the rat nucleus accumbens 114 (see Fig. 1a for location punch needle). These vesicles expressed high levels of various 115 glycosylated forms of VMAT-2 ( Fig. 1b ). Sonication-induced disruption of these vesicles resulted 116 in the liberation of vesicular DA (one-way ANOVA: sonication effect: ( We have previously shown that rats with a high locomotor response (HR) to novelty express 138 more VMAT-2 in their nucleus accumbens when compared to rats with a low locomotor response 139 (LR) to novelty [32] . VMAT-2 is responsible for the transport of both DA and 5-HT into vesicles 140 [43] . We therefore investigated whether animals that differ in their locomotor response to novelty 141 also differ in their dopaminergic and serotonergic storage capacity of the nucleus accumbens. The finding that the amount of DA and 5-HT inside the storage vesicles of the nucleus 159 accumbens are larger in HR than in LR rats (Supplemental Fig. S2 ), together with the finding that 160 COC releases monoamines from these storage vesicles ( Fig. 1) , suggests that COC increases the 161 extracellular levels of these monoamines more strongly in HR than in LR rats. 162
We found that 15 mg/kg COC increased the extracellular accumbal DA and 5-HT levels in Our HR and LR rats have previously been shown not to differ in the duration of walking 175 and rearing following the administration of 15 mg/kg COC [44] . This dose of COC, however, is 176 known to increase the number of automatically collected locomotor activity counts more strongly 177 in HR than in LR [45] . Here we found that 15 mg/kg COC indeed increases the frequency of 178 walking (two-way ANOVA: treatment effect: F(1,29)=61.584, p≤0.001) and rearing (two-way 179 ANOVA: treatment effect: F(1,29)=48.110, p≤0.001) events more strongly in HR than in LR (two-180 way ANOVA: rat type x treatment effect: walking ( walking and rearing: n.s.). Interestingly, the RES-induced reduction in the COC-induced 223 extracellular DA increase ( Fig. 3a ) correlated with a decrease in walking ( Fig. 3g ), but not rearing 224 ( Fig. 3g) . In contrast, the RES-induced reduction in the COC-induced extracellular accumbal HT increase (Fig. 3b ) correlated with a decrease in rearing (Fig. 3g ), but not walking (Fig. 3g) . have also been found to depend on plasmalemmal monoamine re-uptake transporters [50] . In 240 addition, changes in neuronal monoamine re-uptake may contribute to changes in novelty-induced 241 exploration [51] . Therefore, individual differences in the re-uptake of DA and 5-HT by the 242 plasmalemmal dopamine or serotonin transporters (DAT or SERT) may also have contributed to 243 the reported results. To explore this possibility, the neuronal DA and 5-HT uptake was investigated 244 in synaptosomes isolated from the nucleus accumbens of HR and LR rats. We found that the 245 neuronal DA and 5-HT uptake in the nucleus accumbens was concentration dependent (two-way 246 ANOVA: concentration effect: DA: F(5,105)=118.100, p≤0.001 and 5-HT: F(5,105)=268.831, 247 p≤0.001), but not different between HR and LR rats (two-way ANOVA: rat type (x concentration) The individual-specific increase in the extracellular levels of accumbal DA and 5-HT 253 observed after forced exposure to COC (Fig. 2) suggests that HR and LR also differ in the 254 voluntary intake of the drug. To test this hypothesis, HR and LR rats were trained to self-administer 255 COC, after which they were divided into 2 groups that had daily access to the psychostimulant during 1 or 6 hour(s) sessions [8, [40] [41] [42] . In contrast to short access (ShA: 1 p<0.05 and ShA: n.s.). In addition, COC intake correlated with the locomotor response to novelty 263 ( Fig. 4b) . 264 265
Monoaminergic storage vesicles control individual differences in COC self-administration 266 267
The observed RES-induced reduction in the COC-mediated increase of extracellular DA 268 and 5-HT in the nucleus accumbens ( Fig. 3) prompted us to investigate whether RES-induced 269 depletion of monoaminergic storage vesicles also affects the COC intake in HR and LR rats. Since 270 LR rats were marked by a smaller RES-sensitive monoaminergic storage capacity than HR rats 271 (Supplemental Fig. S2 ), COC intake was hypothesized to be reduced by RES more strongly in LR 272 than in HR rats. 1 mg/kg RES did not affect ShA COC self-administration (three way ANOVA: sensitive to the RES-induced reduction in COC intake than HR rats (two-way ANOVA: rat type x 277 treatment effect: ShA (Fig. 5e ): n.s. and LgA (Fig. 5f): F(1,16) =5.248, p<0.05). In LgA rats, the 278 maximum RES-induced decrease in COC intake (Fig. 5f ) was negatively correlated with the 279 locomotor response to novelty (Fig. 5g) . No correlation was found between the locomotor response 14/35 to novelty and the COC intake after applying 1 mg/kg RES to ShA rats (Fig. 5g ), possibly because 281 in these rats this dose of RES did not affect psychostimulant intake (Fig. 5e) . 282
283
To test whether the effects of RES on COC self-administration were dose dependent, a new 284 group of COC-treated HR was pre-treated with 2 mg/kg of the vesicle depleting agent (see also 285 the condition that COC depletes presynaptic storage vesicles, replenishment of these vesicles is 300 required. Indeed, enhanced VMAT-2-dependent monoamine uptake has previously been reported 301 directly following the COC-induced extracellular monoamine peak [52, 53] . Importantly, based 302 on studies by others, vesicular monoamine release into the synaptic cleft is not only VMAT-2, but 303 also Ca 2+ and synapsin, dependent [54] [55] [56] . 304 305 Dopaminergic and serotonergic storage vesicles regulate the neurochemical response 306 variation to COC 307 308 We found that COC increased the accumbal extracellular DA and 5-HT levels more 309 strongly in HR than in LR rats. Although COC has previously been shown to inhibit the reuptake 310 of monoamines by blocking plasmalemmal DA and 5-HT transporters, the finding that HR and 311 LR rats did not differ in the cellular uptake of DA and 5-HT indicates that the observed individual 312 differences in the extracellular accumbal DA and 5-HT response to COC cannot be attributed to 313 individual differences in accumbal plasmalemmal DA and 5-HT transport. In fact, the results 16/35 obtained in RES-treated HR and LR suggest that the individual-specific extracellular DA and HT response to COC is mediated by release from storage vesicles. The observed larger 316 dopaminergic and serotonergic storage capacity in the nucleus accumbens of HR compared to LR 317 is in line with the fact that COC could still increase the extracellular accumbal DA and 5-HT levels 318 in HR, but not in LR pre-treated with 1 mg/kg RES (see Supplemental Fig. S5 ). Accordingly, we 319 conclude that COC leads to a stronger extracellular increase in DA and 5-HT in the nucleus 320 accumbens of HR than of LR, because COC releases more DA and 5-HT from accumbal storage 321 vesicles in HR than in LR (see Supplemental Fig. S5 ). 322 323
Dopaminergic and serotonergic storage vesicles regulate behavioral response variation to 324
COC 325
326
Our data not only support the generally accepted notion that accumbal DA regulates COC-327 induced walking [for review 57] , but also suggest that COC-induced rearing is regulated by 328 accumbal 5-HT. On the basis of the behavioral effects of RES, we hypothesize that the stronger 329 rearing response to COC in HR than in LR is due to a larger COC-induced release of vesicular HT in the nucleus accumbens of HR than of LR. Based on the neurochemical studies of Parsons 331 and Justice [e.g. 58], it has frequently been suggested that the behavioral effects of accumbal HT are due to 5-HT-receptor-mediated changes in the local release of DA [59, 60] . Our data not 333 only indicate that accumbal 5-HT mediates rearing independently of changes in accumbal DA, but 334 also that accumbal DA mediates walking behavior independently of changes in accumbal We hypothesize that the stronger walking response to COC in HR than in LR is due to a stronger 336 COC-induced release of vesicular DA in the nucleus accumbens of HR than of LR. 337
Monoaminergic storage vesicles control COC intake 339 17/35
The finding that 2 mg/kg RES reduced the ShA self-administration of COC, in addition to 341 the finding that both 1 and 2 mg/kg RES reduced COC self-administration under LgA conditions, 342
indicates that monoaminergic storage vesicles do not only control the COC-induced increase in 343 the extracellular levels of accumbal DA and 5-HT, but also the voluntary intake of the 344 psychostimulant. 1 mg/kg RES did not affect the ShA intake of COC, showing that the reduction 345 in either COC intake, or in COC-induced walking and rearing, following RES-induced vesicle 346 depletion does not result from motor impairment. The access-specific effect of 1 mg/kg RES also 347 suggests that COC releases more monoamines from storage vesicles under LgA than under ShA 348 conditions. This is in line with the observed faster recovery of the daily COC intake in ShA versus 349
LgA rats treated with 2 mg/kg of the vesicle depleting agent. 350
351
Storage vesicles control the individual-specific intake of COC 352 353
The positive correlation between locomotor response to novelty and COC self-354 administration is in line with the higher voluntary intake of this psychostimulant in HR than in LR 355 [61] [62] [63] [64] [65] [66] . The observed smaller reduction in the LgA COC intake in HR than in LR that were treated 356 with 1 mg/kg of RES indicates that a larger vesicular DA and 5-HT storage capacity contributes 357 not only to the stronger COC-induced increase in the extracellular levels of these monoamines, 358 but also to the larger LgA intake of COC in HR than in LR. Not only the neurochemical and 359 locomotor responses to COC, but also to high doses of amphetamine are dependent on the amount 360 of monoamines inside storage vesicles [for refs 39, 57] . This indicates that the previously observed 361 stronger locomotor response to amphetamine and the higher intake of this drug in HR than in LR 362 [67] [68] [69] [70] [71] may also have resulted from a stronger amphetamine-induced release of DA and/or 5-HT 363 from accumbal storage vesicles in HR than in LR. Intrestingly, the fact that 1 mg/kg RES did not 364 affect the ShA intake of COC in both HR and LR, whereas this dose of the vesicle depleter was 365 shown to strongly reduce the extracellular increase of accumbal monoamines in these rats, suggests that a mode of action different from an increase of extracellular DA and 5-HT in the nucleus 367 accumbens may contribute to the rewarding effects of ShA exposure to cocaine. It remains to be 368 investigated if this novel mode of action involves different neurotransmitters and/or changes in 369 different brain regions. 370 371
Storage vesicles may control the effects of COC in individuals lacking plasmalemmal 372
transporters 373 374 Our finding that, apart from affecting plasmalemmal monoamine transporters, COC is able 375 to increase extracellular monoamine levels may very well explain the previously reported 376 unexpected intake of and behavioral response to COC in rodents lacking the plasmalemmal 377 transporters [7, 8, 25, 26] . Such a monoamine-releasing action of COC may also explain why a 378 reduction in plasmalemmal transporter gene expression does not eliminate the intake of COC by 379 humans [22] [23] [24] . The transporter-independent mechanism of COC to increase the vesicular release 380 of monoamines is still unknown. In this respect, it is interesting to note that COC stimulates sigma-381 1 receptors [for review 72] , which in turn increases both 5-HT and DA release [73, 74] . 382 383 384
Conclusions 385
386 Altogether, our study shows that COC increases the extracellular concentrations of 387 accumbal DA and 5-HT by depleting presynaptic storage vesicles, and that individual differences 388 in the response to COC are mediated by individual differences in monoaminergic storage capacity. 389 Therefore, storage vesicles may serve as an attractive novel drug target to develop inhibitors of 390 psychostimulant intake. Our finding that RES inhibits the accumbal extracellular DA increase together with the generally accepted notion that accumbal DA mediates reward [1] [2] [3] [4] suggests that 392 RES reduced COC intake by interfering with the reinforcing properties of the psychostimulant. 393
Given that extracellular 5-HT may also modulate reward [15, 20, 75, 76] , future studies should 394 focus not only on the manipulation of dopaminergic, but also of serotonergic storage vesicles as a 395 potential therapy to inhibit the intake of COC. the nucleus accumbens significantly correlated with an increase in COC-induced walking, but not 418 rearing (i). In contrast, the COC-induced depletion of the serotonergic storage vesicles of the 419 nucleus accumbens significantly correlated with an increase in COC-induced rearing, but not 420 walking (i). *Significant difference between sonicated (+sc) and non-sonicated (-sc) P5 vesicular 421 fraction or between saline (sal)-and COC-treated rats (one-way ANOVA: p<0.05). All data are 422 expressed as mean ± SEM. 423
